Successful use of immune checkpoint Inhibition in a patient with myasthenia gravis and recurrent endometrial cancer- expanding access beyond initial clinical trial eligibility

免疫检查点抑制剂成功用于治疗重症肌无力合并复发性子宫内膜癌患者——扩大了其应用范围，使其不再局限于最初的临床试验入组标准